Lithium Ion

Lithium Ion

SCHEMBL7704515

COc1ccc2c(c1)CC[C@H](CN(C)CC(=O)[O-])[C@@H]2c1ccc(F)cc1F.[Li+]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 4/20 0.60
HSD17B2 P37059 2/20 0.38
RORC P51449 1/20 0.37
HTR6 P50406 3/20 0.37
PPARD Q03181 2/20 0.37
CPS1 P31327 2/20 0.36
NQO2 P16083 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL7706037 0.90 SLC6A9 (0.69) SLC6A9HSD17B2HTR6PPARDNQO2
Lithium Ion SCHEMBL7706192 0.86 SLC6A9 (0.64) SLC6A9HSD17B2RORCPPARDNQO2
Lithium Ion SCHEMBL7703313 0.85 SLC6A9 (0.74) SLC6A9HSD17B2PPARDMTNR1ACA1
Org-25935 SCHEMBL7704305 0.83 SLC6A9 (0.85) SLC6A9PPARDMTNR1AMTNR1BCA1
Org-25935 SCHEMBL7703028 0.83 SLC6A9 (0.85) SLC6A9PPARDMTNR1AMTNR1BCA1
Lithium Ion SCHEMBL7698371 0.81 SLC6A9 (0.53) SLC6A9HTR6MTNR1AMTNR1B
Lithium Ion SCHEMBL7705019 0.80 SLC6A9 (0.56) SLC6A9HTR6PPARDCA1CA2
Lithium Ion SCHEMBL7703444 0.79 SLC6A9 (0.62) SLC6A9HTR6MTNR1AMTNR1B
Lithium Ion SCHEMBL7698462 0.76 SLC6A9 (0.69) SLC6A9PPARDMTNR1AMTNR1B
Lithium Ion SCHEMBL7706983 0.76 SLC6A9 (0.71) SLC6A9NQO2MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed